A Phase Ib/II Clinical Study on AK112 Combined or Not Combined With AK119 in pMMR/MSS Colorectal Cancer
A phase 1/2 trial of AK119, Ivonescimab, CAPOX in colorectal cancer, run by Akeso, active and no longer recruiting.
Overview
A Phase Ib/II Clinical Study on AK112 Combined or Not Combined With AK119 in pMMR/MSS Colorectal Cancer is a phase 1/2 interventional study registered as NCT05846867 by Akeso, with 170 participants planned, started 2023-05-08 and due to reach its primary completion in 2026-05-08. Interventions recorded: AK119, AK112, Oxaliplatin, Irinotecan, Calcium folinate. Conditions listed: Colorectal Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
Shares FOLFIRI (5-FU, leucovorin, irinotecan), CAPOX (capecitabine, oxaliplatin), Ivonescimab, Akeso.
- TrialBOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
Shares Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Fluorouracil (5-FU), Colorectal cancer.
- TrialNeoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer
Shares Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Akeso, Colorectal cancer.
- TrialStudy to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unrese
Shares Leucovorin (folinic acid), FOLFIRI (5-FU, leucovorin, irinotecan), Fluorouracil (5-FU), Colorectal cancer.
- TrialA Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
Shares FOLFIRI (5-FU, leucovorin, irinotecan), CAPOX (capecitabine, oxaliplatin), Fluorouracil (5-FU), Colorectal cancer.
- TrialStudy of AK119 Combined With AK112 in Patients With Advanced Solid Tumors
- TrialHSK42360-Na Tablets Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal Cancer
Shares FOLFIRI (5-FU, leucovorin, irinotecan), CAPOX (capecitabine, oxaliplatin), Colorectal cancer.
- TrialStudy of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-muta
Shares Leucovorin (folinic acid), FOLFIRI (5-FU, leucovorin, irinotecan), CAPOX (capecitabine, oxaliplatin).